| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Application of clinical trial inclusion criteria to clinical practice patients to quantify the burden of CNS metastases on health-related quality of life and healthcare resource use in patients with NSCLC
|
Crane, Gracy
|
|
|
149 |
C |
p. 144-153
|
artikel
|
| 2 |
Characteristics and response to crizotinib in lung cancer patients with MET amplification detected by next-generation sequencing
|
Li, Jingwen
|
|
|
149 |
C |
p. 17-22
|
artikel
|
| 3 |
Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients – A single centre experience
|
Dall’Olio, Filippo G.
|
|
|
149 |
C |
p. 5-9
|
artikel
|
| 4 |
Concurrent use of aspirin with osimertinib is associated with improved survival in advanced EGFR-mutant non-small cell lung cancer
|
Liu, Xiaoke
|
|
|
149 |
C |
p. 33-40
|
artikel
|
| 5 |
Contents
|
|
|
|
149 |
C |
p. v-vi
|
artikel
|
| 6 |
Distribution of EML4-ALK fusion variants and clinical outcomes in patients with resected non-small cell lung cancer
|
Tao, Hong
|
|
|
149 |
C |
p. 154-161
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
149 |
C |
p. iii
|
artikel
|
| 8 |
ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancer
|
Reissig, Timm M.
|
|
|
149 |
C |
p. 10-16
|
artikel
|
| 9 |
Everolimus in the treatment of metastatic thymic epithelial tumors
|
Hellyer, Jessica A.
|
|
|
149 |
C |
p. 97-102
|
artikel
|
| 10 |
Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases
|
Zhao, Jing
|
|
|
149 |
C |
p. 90-96
|
artikel
|
| 11 |
Impact of the preoperative body mass index on the postoperative outcomes in patients with completely resected non-small cell lung cancer: A retrospective analysis of 16,503 cases in a Japanese Lung Cancer Registry Study
|
Fukumoto, Koichi
|
|
|
149 |
C |
p. 120-129
|
artikel
|
| 12 |
KRAS G12D mutation predicts lower TMB and drives immune suppression in lung adenocarcinoma
|
Gao, Ge
|
|
|
149 |
C |
p. 41-45
|
artikel
|
| 13 |
Lung cancer screening intervals based on cancer risk
|
Zhang, Li
|
|
|
149 |
C |
p. 113-119
|
artikel
|
| 14 |
Nationwide effect of high procedure volume in lung cancer surgery on in-house mortality in Germany
|
Baum, Philip
|
|
|
149 |
C |
p. 78-83
|
artikel
|
| 15 |
Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III study
|
Goldman, Jonathan W.
|
|
|
149 |
C |
p. 46-52
|
artikel
|
| 16 |
Prognostic significance of spread through air spaces in pulmonary metastases from colorectal cancer
|
Takeda-Miyata, Naoko
|
|
|
149 |
C |
p. 61-67
|
artikel
|
| 17 |
Re-biopsy after first line treatment in advanced NSCLC can reveal changes in PD-L1 expression
|
Frank, Malene Støchkel
|
|
|
149 |
C |
p. 23-32
|
artikel
|
| 18 |
Robust assessment of tumor mutational burden in cytological specimens from lung cancer patients
|
Alborelli, Ilaria
|
|
|
149 |
C |
p. 84-89
|
artikel
|
| 19 |
Sarcopenia as independent risk factor of postpneumonectomy respiratory failure, ARDS and mortality
|
Martini, Katharina
|
|
|
149 |
C |
p. 130-136
|
artikel
|
| 20 |
Spectrum of uncommon and compound epidermal growth factor receptor mutations in non-small-cell lung carcinomas with treatment response and outcome analysis: A study from India
|
Singh, Varsha
|
|
|
149 |
C |
p. 53-60
|
artikel
|
| 21 |
Stereotactic radiosurgery for brain metastases: A retrospective cohort study comparing treatment results between two lung cancer patient age groups, 75 years or older vs 65–74 years
|
Yamamoto, Masaaki
|
|
|
149 |
C |
p. 103-112
|
artikel
|
| 22 |
The Dutch Lung Cancer Audit: Nationwide quality of care evaluation of lung cancer patients
|
Ismail, R.K.
|
|
|
149 |
C |
p. 68-77
|
artikel
|
| 23 |
Value of interim 18F-FDG PET/CT for predicting progression-free survival in stage ⅢB/IV EGFR-mutant non–small-cell lung cancer patients with EGFR-TKI therapy
|
Shao, Dan
|
|
|
149 |
C |
p. 137-143
|
artikel
|
| 24 |
Whole exome sequencing reveals BAP1 somatic abnormalities in mesothelioma in situ
|
Dacic, Sanja
|
|
|
149 |
C |
p. 1-4
|
artikel
|
Tijdschrift beschrijving